# clinical-trial-stats

Clinical trial sample size calculation and statistical analysis library.

ä¸´åºŠè¯•éªŒæ ·æœ¬é‡è®¡ç®—ä¸ç»Ÿè®¡åˆ†æå·¥å…·åº“ã€‚

## Features | åŠŸèƒ½

- **Sample Size Calculation | æ ·æœ¬é‡è®¡ç®—** â€” Non-inferiority, superiority, equivalence (TOST), one-sample, paired (McNemar), multi-group (Bonferroni) | éåŠ£æ•ˆã€ä¼˜æ•ˆã€ç­‰æ•ˆ (TOST)ã€å•ç»„ã€é…å¯¹ (McNemar)ã€å¤šç»„ (Bonferroni)
- **Result Validation | ç»“æœéªŒè¯** â€” Hypothesis testing with Farrington-Manning RMLE, Miettinen-Nurminen, Wilson Score CI | å‡è®¾æ£€éªŒï¼Œæ”¯æŒ FMã€MNã€Wilson Score ç­‰æ–¹æ³•
- **Confidence Interval Estimation | ç½®ä¿¡åŒºé—´ä¼°ç®—** â€” Proportion CI (Wilson Score), Mean CI (Normal approximation) | ç‡çš„ CI (Wilson Score)ã€å‡å€¼çš„ CI (æ­£æ€è¿‘ä¼¼)
- **Effect Size | æ•ˆåº”é‡** â€” Cohen's d (continuous), Cohen's h (proportion, arcsine transformation) | è¿ç»­ç»ˆç‚¹ Cohen's dã€ç‡ç»ˆç‚¹ Cohen's h
- **Sensitivity Analysis | æ•æ„Ÿæ€§åˆ†æ** â€” Parameter sweep across trial design parameters | å‚æ•°æ‰«æï¼Œè§‚å¯Ÿæ ·æœ¬é‡éšå‚æ•°å˜åŒ–çš„è¶‹åŠ¿
- **Both Endpoints | åŒç»ˆç‚¹æ”¯æŒ** â€” Each method supports both proportion and continuous endpoints | æ¯ç§æ–¹æ³•å‡æ”¯æŒç‡ç»ˆç‚¹å’Œè¿ç»­ç»ˆç‚¹
- **Zero Dependencies | é›¶ä¾èµ–** â€” Pure JavaScript, runs in Node.js, browser, or any JS environment | çº¯ JavaScriptï¼Œå¯è¿è¡Œäº Node.jsã€æµè§ˆå™¨æˆ–ä»»ä½• JS ç¯å¢ƒ

## Status | å¼€å‘è¿›åº¦

| Module | Proportion | Continuous | Tests | Verified Against | æ¨¡å— |
|--------|:----------:|:----------:|:-----:|------------------|------|
| **Sample Size Calculation** | | | | | **æ ·æœ¬é‡è®¡ç®—** |
| Non-inferiority (two-group) | âœ… | âœ… | âœ… | â€” | éåŠ£æ•ˆï¼ˆä¸¤ç»„ï¼‰ |
| Superiority (two-group) | âœ… | âœ… | âœ… | â€” | ä¼˜æ•ˆï¼ˆä¸¤ç»„ï¼‰ |
| Equivalence / TOST (two-group) | âœ… | âœ… | âœ… | â€” | ç­‰æ•ˆï¼ˆä¸¤ç»„ï¼‰ |
| One-sample | âœ… | âœ… | ğŸ”² | â€” | å•ç»„è¯•éªŒ |
| Paired design (McNemar) | âœ… | âœ… | ğŸ”² | â€” | é…å¯¹è®¾è®¡ |
| Multi-group (Bonferroni) | âœ… | âœ… | ğŸ”² | â€” | å¤šç»„æ¯”è¾ƒ |
| **Result Validation** | | | | | **ç»“æœéªŒè¯** |
| Two-group (Wald / FM / MN) | âœ… | âœ… | ğŸ”² | â€” | ä¸¤ç»„ï¼ˆWald / FM / MNï¼‰ |
| One-sample | âœ… | âœ… | ğŸ”² | â€” | å•ç»„ |
| Paired (McNemar) | âœ… | âœ… | ğŸ”² | â€” | é…å¯¹ |
| Multi-group | âœ… | âœ… | ğŸ”² | â€” | å¤šç»„ |
| **Other Modules** | | | | | **å…¶ä»–æ¨¡å—** |
| Proportion CI (Wilson Score) | âœ… | â€” | ğŸ”² | â€” | ç‡çš„ç½®ä¿¡åŒºé—´ |
| Mean CI (Normal approx.) | â€” | âœ… | ğŸ”² | â€” | å‡å€¼ç½®ä¿¡åŒºé—´ |
| Effect size (Cohen's d / h) | âœ… | âœ… | âœ… | â€” | æ•ˆåº”é‡ |
| Sensitivity analysis | âœ… | âœ… | ğŸ”² | â€” | æ•æ„Ÿæ€§åˆ†æ |
| Internal: normal distribution, floating-point precision | â€” | â€” | âœ… | â€” | å†…éƒ¨ä¾èµ–ï¼šæ­£æ€åˆ†å¸ƒå‡½æ•°ã€æµ®ç‚¹ç²¾åº¦å¤„ç† |

âœ… Done | å·²å®Œæˆ &emsp; ğŸ”² Planned | å¾…è¡¥å…… &emsp; **Verified Against**: third-party software used for cross-validation (e.g. R, SAS, PASS) â€” to be updated after each formal test | **å¯¹ç…§éªŒè¯**ï¼šç”¨äºäº¤å‰éªŒè¯çš„ç¬¬ä¸‰æ–¹è½¯ä»¶ï¼ˆå¦‚ Rã€SASã€PASSï¼‰ï¼Œæ¯å®Œæˆä¸€é¡¹æ­£å¼æµ‹è¯•åæ›´æ–°

## Install | å®‰è£…

```bash
npm install clinical-trial-stats
```

## Quick Start | å¿«é€Ÿå¼€å§‹

```javascript
import {
  calculateNISampleSize,
  calculateSupSampleSize,
  calculateEqSampleSize
} from 'clinical-trial-stats'

// Non-inferiority trial (proportion endpoint)
// éåŠ£æ•ˆè¯•éªŒï¼ˆç‡ç»ˆç‚¹ï¼‰
// Control: 85%, Treatment: 85%, Margin: 10%, Alpha: 2.5% (one-sided), Power: 80%
const ni = calculateNISampleSize(0.85, 0.85, 0.1, 0.025, 0.8, 1)
// => { n1: 284, n2: 284 }

// Superiority trial (proportion endpoint)
// ä¼˜æ•ˆè¯•éªŒï¼ˆç‡ç»ˆç‚¹ï¼‰
// Control: 70%, Treatment: 85%, Alpha: 2.5%, Power: 80%
const sup = calculateSupSampleSize(0.70, 0.85, 0.025, 0.8, 1)
// => { n1: 71, n2: 71 }

// Equivalence trial (TOST, proportion endpoint)
// ç­‰æ•ˆè¯•éªŒï¼ˆTOSTï¼Œç‡ç»ˆç‚¹ï¼‰
// Both groups: 30%, Margin: 5%, Alpha: 2.5%, Power: 80%
const eq = calculateEqSampleSize(0.3, 0.3, 0.05, 0.025, 0.8, 1)
// => { n1: 832, n2: 832 }
```

## API

### Sample Size Calculation | æ ·æœ¬é‡è®¡ç®—

| Function | Description | è¯´æ˜ |
|----------|-------------|------|
| `calculateNISampleSize(p1, p2, delta, alpha, power, ratio)` | Non-inferiority, proportion | éåŠ£æ•ˆï¼Œç‡ç»ˆç‚¹ |
| `calculateNISampleSizeContinuous(sigma, delta, alpha, power, ratio, meanDiff)` | Non-inferiority, continuous | éåŠ£æ•ˆï¼Œè¿ç»­ç»ˆç‚¹ |
| `calculateSupSampleSize(p1, p2, alpha, power, ratio)` | Superiority, proportion | ä¼˜æ•ˆï¼Œç‡ç»ˆç‚¹ |
| `calculateSupSampleSizeContinuous(sigma, meanDiff, alpha, power, ratio)` | Superiority, continuous | ä¼˜æ•ˆï¼Œè¿ç»­ç»ˆç‚¹ |
| `calculateEqSampleSize(p1, p2, delta, alpha, power, ratio)` | Equivalence (TOST), proportion | ç­‰æ•ˆ (TOST)ï¼Œç‡ç»ˆç‚¹ |
| `calculateEqSampleSizeContinuous(sigma, delta, alpha, power, ratio, meanDiff)` | Equivalence (TOST), continuous | ç­‰æ•ˆ (TOST)ï¼Œè¿ç»­ç»ˆç‚¹ |
| `calculateOneSampleSize(p0, p1, alpha, power)` | One-sample, proportion | å•ç»„ï¼Œç‡ç»ˆç‚¹ |
| `calculateOneSampleSizeContinuous(mu0, mu1, sigma, alpha, power)` | One-sample, continuous | å•ç»„ï¼Œè¿ç»­ç»ˆç‚¹ |
| `calculatePairedSampleSize(p10, p01, delta, alpha, power, studyType)` | Paired (McNemar), proportion | é…å¯¹ (McNemar)ï¼Œç‡ç»ˆç‚¹ |
| `calculatePairedSampleSizeContinuous(sigma_diff, mean_diff, delta, alpha, power, studyType)` | Paired t-test, continuous | é…å¯¹ t æ£€éªŒï¼Œè¿ç»­ç»ˆç‚¹ |
| `calculateMultigroupSampleSize(p0, p_groups, delta, alpha, power, studyType, allocations, strategy)` | Multi-group, proportion | å¤šç»„ï¼Œç‡ç»ˆç‚¹ |
| `calculateMultigroupSampleSizeContinuous(mean0, mean_groups, sd, delta, alpha, power, studyType, allocations, strategy)` | Multi-group, continuous | å¤šç»„ï¼Œè¿ç»­ç»ˆç‚¹ |

### Result Validation (Hypothesis Testing) | ç»“æœéªŒè¯ï¼ˆå‡è®¾æ£€éªŒï¼‰

| Function | Description | è¯´æ˜ |
|----------|-------------|------|
| `calculateNIResult(n1, x1, n2, x2, delta, alpha)` | Non-inferiority test | éåŠ£æ•ˆæ£€éªŒ |
| `calculateSupResult(n1, x1, n2, x2, alpha)` | Superiority test | ä¼˜æ•ˆæ£€éªŒ |
| `calculateEqResult(n1, x1, n2, x2, delta, alpha)` | Equivalence test | ç­‰æ•ˆæ£€éªŒ |
| `calculateOneSampleResult(n, s, p0, alpha, useContinuity)` | One-sample test | å•ç»„æ£€éªŒ |
| `calculatePairedResult(n10, n01, delta, alpha, useContinuity, studyType)` | Paired test (McNemar) | é…å¯¹æ£€éªŒ (McNemar) |
| `calculateMultigroupResult(n0, x0, n_groups, x_groups, delta, alpha, studyType, allocations, strategy)` | Multi-group test | å¤šç»„æ£€éªŒ |

Continuous variants available for all result validation functions (append `Continuous` to function name).

æ‰€æœ‰ç»“æœéªŒè¯å‡½æ•°å‡æœ‰è¿ç»­ç»ˆç‚¹ç‰ˆæœ¬ï¼ˆå‡½æ•°åæœ«å°¾åŠ  `Continuous`ï¼‰ã€‚

### Confidence Interval Estimation | ç½®ä¿¡åŒºé—´ä¼°ç®—

| Function | Description | è¯´æ˜ |
|----------|-------------|------|
| `calculateRateCISampleSize(p, width, alpha)` | Sample size for proportion CI | ç‡çš„ CI æ‰€éœ€æ ·æœ¬é‡ |
| `calculateRateCI(n, x, alpha)` | Proportion CI (Wilson Score) | ç‡çš„ç½®ä¿¡åŒºé—´ |
| `calculateMeanCISampleSize(sigma, width, alpha)` | Sample size for mean CI | å‡å€¼ CI æ‰€éœ€æ ·æœ¬é‡ |
| `calculateMeanCI(n, mean, sd, alpha)` | Mean CI (Normal approximation) | å‡å€¼ç½®ä¿¡åŒºé—´ |

### Effect Size | æ•ˆåº”é‡

| Function | Description | è¯´æ˜ |
|----------|-------------|------|
| `calculateCohenD(meanDiff, sigma)` | Cohen's d for continuous endpoints | è¿ç»­ç»ˆç‚¹æ•ˆåº”é‡ |
| `calculateCohenH(p1, p2)` | Cohen's h for proportion endpoints | ç‡ç»ˆç‚¹æ•ˆåº”é‡ |
| `interpretCohenD(d)` | Interpret effect size level | æ•ˆåº”é‡ç­‰çº§è§£è¯» |
| `getEffectSizeInfo(meanDiff, sigma)` | Full effect size report | å®Œæ•´æ•ˆåº”é‡æŠ¥å‘Š |

### Sensitivity Analysis | æ•æ„Ÿæ€§åˆ†æ

| Function | Description | è¯´æ˜ |
|----------|-------------|------|
| `runSensitivityAnalysis(mode, baseParams, config)` | Parameter sweep analysis | å‚æ•°æ‰«æåˆ†æ |

### Core Utilities | æ ¸å¿ƒå·¥å…·

| Function | Description | è¯´æ˜ |
|----------|-------------|------|
| `normalCDF(x)` | Standard normal CDF | æ ‡å‡†æ­£æ€åˆ†å¸ƒç´¯ç§¯åˆ†å¸ƒå‡½æ•° |
| `normalInverse(p)` | Inverse normal (quantile function) | æ­£æ€åˆ†å¸ƒé€†å‡½æ•°ï¼ˆåˆ†ä½æ•°å‡½æ•°ï¼‰ |

## Parameters | å‚æ•°è¯´æ˜

All proportion parameters use **decimal scale** (0-1), not percentages:

æ‰€æœ‰ç‡å‚æ•°ä½¿ç”¨**å°æ•°åˆ¶** (0-1)ï¼Œè€Œéç™¾åˆ†æ¯”ï¼š

- `p1 = 0.85` means 85% | è¡¨ç¤º 85%
- `alpha = 0.025` means 2.5% (one-sided) | è¡¨ç¤ºå•ä¾§ 2.5%
- `power = 0.8` means 80% | è¡¨ç¤º 80%
- `delta = 0.1` means 10% margin | è¡¨ç¤º 10% ç•Œå€¼
- `ratio` = allocation ratio n2/n1 (default: 1 for equal allocation) | åˆ†é…æ¯”ä¾‹ n2/n1ï¼ˆé»˜è®¤ 1:1 ç­‰æ¯”åˆ†é…ï¼‰

## Formulas | å…¬å¼

### Non-Inferiority (Two-Group) | éåŠ£æ•ˆï¼ˆä¸¤ç»„æ¯”è¾ƒï¼‰

**Proportion endpoint | ç‡ç»ˆç‚¹ï¼š**

$$n_1 = \frac{(Z_{1-\alpha} + Z_{1-\beta})^2 \cdot [p_1(1-p_1) + p_2(1-p_2)/k]}{[(p_2 - p_1) + \delta]^2}$$

**Continuous endpoint | è¿ç»­ç»ˆç‚¹ï¼š**

$$n_1 = \frac{(Z_{1-\alpha} + Z_{1-\beta})^2 \cdot \sigma^2 \cdot (1 + 1/k)}{[(\mu_2 - \mu_1) + |\delta|]^2}$$

> Chow et al. (2017) Chapter 4; Julious & Campbell (2012) *Stat Med* 31:2904-2936

### Superiority (Two-Group) | ä¼˜æ•ˆï¼ˆä¸¤ç»„æ¯”è¾ƒï¼‰

**Proportion endpoint | ç‡ç»ˆç‚¹ï¼š**

$$n_1 = \frac{(Z_{1-\alpha} + Z_{1-\beta})^2 \cdot [p_1(1-p_1) + p_2(1-p_2)/k]}{(p_2 - p_1)^2}$$

**Continuous endpoint | è¿ç»­ç»ˆç‚¹ï¼š**

$$n_1 = \frac{(Z_{1-\alpha} + Z_{1-\beta})^2 \cdot \sigma^2 \cdot (1 + 1/k)}{(\mu_2 - \mu_1)^2}$$

> Chow et al. (2017) Chapter 4

### Equivalence â€” TOST (Two-Group) | ç­‰æ•ˆ â€” TOSTï¼ˆä¸¤ç»„æ¯”è¾ƒï¼‰

Uses dynamic Z-value selection based on whether the expected difference is zero.

æ ¹æ®é¢„æœŸå·®å¼‚æ˜¯å¦ä¸ºé›¶ï¼ŒåŠ¨æ€é€‰æ‹© Z å€¼ã€‚

**When pâ‚ = pâ‚‚ (symmetric TOST) | å½“ pâ‚ = pâ‚‚ï¼ˆå¯¹ç§° TOSTï¼‰ï¼š**

$$n_1 = \frac{(Z_{1-\alpha} + Z_{1-\beta/2})^2 \cdot [p_1(1-p_1) + p_2(1-p_2)/k]}{\delta^2}$$

**When pâ‚ â‰  pâ‚‚ (asymmetric TOST) | å½“ pâ‚ â‰  pâ‚‚ï¼ˆéå¯¹ç§° TOSTï¼‰ï¼š**

$$n_1 = \frac{(Z_{1-\alpha} + Z_{1-\beta})^2 \cdot [p_1(1-p_1) + p_2(1-p_2)/k]}{[\delta - |p_2 - p_1|]^2}$$

> Julious (2009) Chapter 6; Flight & Julious (2016) *Pharm Stat* 15(1):80-89; Phillips (1990) *J Pharmacokinet Biopharm* 18(2):137-144

### One-Sample | å•ç»„è¯•éªŒ

**Proportion endpoint | ç‡ç»ˆç‚¹ï¼š**

$$n = \frac{[Z_{1-\alpha}\sqrt{p_0(1-p_0)} + Z_{1-\beta}\sqrt{p_1(1-p_1)}]^2}{(p_1 - p_0)^2}$$

**Continuous endpoint | è¿ç»­ç»ˆç‚¹ï¼š**

$$n = \frac{(Z_{1-\alpha} + Z_{1-\beta})^2 \cdot \sigma^2}{(\mu_1 - \mu_0)^2}$$

### Paired Design | é…å¯¹è®¾è®¡

**Proportion endpoint (McNemar test) | ç‡ç»ˆç‚¹ï¼ˆMcNemar æ£€éªŒï¼‰ï¼š**

$$n = \frac{(Z_{1-\alpha} + Z_{1-\beta})^2 \cdot (p_{10} + p_{01})}{(p_{10} - p_{01} - \delta)^2}$$

Where pâ‚â‚€ and pâ‚€â‚ are discordant pair proportions.

å…¶ä¸­ pâ‚â‚€ å’Œ pâ‚€â‚ ä¸ºä¸ä¸€è‡´é…å¯¹çš„æ¯”ä¾‹ã€‚

**Continuous endpoint (paired t-test) | è¿ç»­ç»ˆç‚¹ï¼ˆé…å¯¹ t æ£€éªŒï¼‰ï¼š**

$$n = \frac{(Z_{1-\alpha} + Z_{1-\beta})^2 \cdot \sigma_{diff}^2}{\text{effect size}^2}$$

### Multi-Group (Bonferroni) | å¤šç»„æ¯”è¾ƒï¼ˆBonferroni æ ¡æ­£ï¼‰

Applies Bonferroni correction for multiple comparisons.

å¯¹å¤šé‡æ¯”è¾ƒè¿›è¡Œ Bonferroni æ ¡æ­£ï¼š

$$\alpha_{adjusted} = \alpha / k \quad \text{(strategy = 'any')}$$

$$n_i = \frac{(Z_{1-\alpha_{adj}} + Z_{1-\beta})^2 \cdot [p_0(1-p_0)/r_0 + p_i(1-p_i)/r_i]}{\text{effect size}^2}$$

Supports unequal allocation via weights array `[râ‚€, râ‚, râ‚‚, ...]`.

æ”¯æŒé€šè¿‡æƒé‡æ•°ç»„ `[râ‚€, râ‚, râ‚‚, ...]` è¿›è¡Œä¸ç­‰æ¯”ä¾‹åˆ†é…ã€‚

### Confidence Interval | ç½®ä¿¡åŒºé—´

**Proportion (Wilson Score) | ç‡ï¼ˆWilson Score æ³•ï¼‰ï¼š**

$$n \approx \frac{Z^2 \cdot p(1-p)}{w^2}$$

**Mean | å‡å€¼ï¼š**

$$n = \left(\frac{Z \cdot \sigma}{w}\right)^2$$

### Effect Size | æ•ˆåº”é‡

**Cohen's d** (continuous | è¿ç»­ç»ˆç‚¹): $\quad d = \dfrac{\mu_1 - \mu_2}{\sigma}$

**Cohen's h** (proportion | ç‡ç»ˆç‚¹): $\quad h = 2[\arcsin(\sqrt{p_1}) - \arcsin(\sqrt{p_2})]$

Interpretation | è§£è¯»: negligible | æå° (<0.2), small | å° (0.2â€“0.5), medium | ä¸­ (0.5â€“0.8), large | å¤§ (â‰¥0.8)

### Result Validation | ç»“æœéªŒè¯

Hypothesis testing supports three methods for two-group proportion comparisons.

ä¸¤ç»„ç‡ç»ˆç‚¹çš„å‡è®¾æ£€éªŒæ”¯æŒä¸‰ç§æ–¹æ³•ï¼š

| Method | Description | è¯´æ˜ | Reference |
|--------|-------------|------|-----------|
| **Wald** | Normal approximation with observed rates | åŸºäºè§‚æµ‹ç‡çš„æ­£æ€è¿‘ä¼¼ | Classic |
| **Farrington-Manning** | RMLE under Hâ‚€, Newton-Raphson iteration | Hâ‚€ çº¦æŸä¸‹çš„ RMLEï¼ŒNewton-Raphson è¿­ä»£ | Farrington & Manning (1990) |
| **Miettinen-Nurminen** | Score method, matches SAS PROC FREQ | Score æ³•ï¼Œä¸ SAS PROC FREQ ç»“æœä¸€è‡´ | Miettinen & Nurminen (1985) *Stat Med* |

## References | å‚è€ƒæ–‡çŒ®

1. Chow SC, Shao J, Wang H, Lokhnygina Y. *Sample Size Calculations in Clinical Research*. 3rd ed. Chapman and Hall/CRC; 2017.
2. Julious SA. *Sample Sizes for Clinical Trials*. Chapman and Hall/CRC; 2009.
3. Flight L, Julious SA. Practical guide to sample size calculations: non-inferiority and equivalence trials. *Pharm Stat*. 2016;15(1):80-89.
4. Julious SA, Campbell MJ. Tutorial in biostatistics: sample sizes for parallel group clinical trials with binary data. *Stat Med*. 2012;31:2904-2936.
5. Phillips KF. Power of the Two One-Sided Tests Procedure in Bioequivalence. *J Pharmacokinet Biopharm*. 1990;18(2):137-144.
6. Miettinen O, Nurminen M. Comparative analysis of two rates. *Stat Med*. 1985;4(2):213-226.
7. Farrington CP, Manning G. Test statistics and sample size formulae for comparative binomial trials with null hypothesis of non-zero risk difference or non-unity relative risk. *Stat Med*. 1990;9(12):1447-1454.
8. Newcombe RG. Interval estimation for the difference between independent proportions. *Stat Med*. 1998;17(8):873-890.
9. NMPA. è¯ç‰©ä¸´åºŠè¯•éªŒæ ·æœ¬é‡ä¼°è®¡æŒ‡å¯¼åŸåˆ™ (2023).

## Test | æµ‹è¯•

```bash
npm test
```

Tests are validated against published literature results and established statistical software (R, SAS).

æµ‹è¯•ç”¨ä¾‹åŸºäºå·²å‘è¡¨æ–‡çŒ®ç»“æœå’Œæˆç†Ÿç»Ÿè®¡è½¯ä»¶ï¼ˆRã€SASï¼‰è¿›è¡Œäº¤å‰éªŒè¯ã€‚

## About | å…³äº

This library is created by **ææ’éª** ([lihj.net](https://lihj.net)) and [Claude Code](https://claude.ai/claude-code) (Anthropic).

Built through human-AI collaboration. The author provides clinical trial domain expertise, makes all design decisions, and validates calculations against peer-reviewed literature. Claude Code implements the algorithms and writes the test suite.

æœ¬é¡¹ç›®é€šè¿‡äººæœºåä½œå®Œæˆã€‚ä½œè€…æä¾›ä¸´åºŠè¯•éªŒé¢†åŸŸä¸“ä¸šçŸ¥è¯†ï¼Œä¸»å¯¼æ‰€æœ‰è®¾è®¡å†³ç­–ï¼Œå¹¶åŸºäºåŒè¡Œè¯„å®¡æ–‡çŒ®éªŒè¯è®¡ç®—ç»“æœçš„æ­£ç¡®æ€§ã€‚Claude Code è´Ÿè´£ç®—æ³•å®ç°ä¸æµ‹è¯•ç¼–å†™ã€‚

## License | è®¸å¯è¯

[MIT](LICENSE)
